My mother’s #Alzheimers

Back in February 2015, a friend of mine in NY inspired me to blog about my experience with my mother’s Alzheimer’s Disease. So far, I had only blogged once about her condition since her diagnosis in 2001, three years ago, and tweeted about it here and there, during particularly difficult times.

My mother has Alzheimer’s Disease
She was “diagnosed” in 2011. Back in 2011, she was 81. Now she is 85, and you can guess: things haven’t gotten better.

She used to be a very go-getter type person, very independent. One day I dropped her off in church (she used to drive back then, but she wanted me to drive her). I told her I’d wait for her outside in one hour. An hour went by, and she wouldn’t come out… nearly 20 minutes after the hour, she called me from her apartment.

She had gotten a ride home with a fellow parishioner… she had all forgotten that I was going to pick her up. This event, combined with a couple of instances of her getting lost in the Berkeley traffic (those of you who’ve lived here know this to be a joke!) raised a red flag.

We brought her to a geriatric specialist who confirmed the “diagnosis”. I use double-quotes because, unlike things like diabetes, where you can test your fasting blood sugar and establishing nearly without doubt if someone has the condition or not, with Alzheimer’s, it is trickier. As the Alzheimer’s Association would say:

There is no single test that can show whether a person has Alzheimer’s.

Of the 10 early signs of Alzheimer’s, back in 2011 my mom had 6. She now has 7.

In the coming months and years (however long she has left with us), I will share bits and pieces of my mom’s Alzheimer’s story, using the alzheimers tag in this blog.

For now, I leave you with a photo of her and her grandson (my son) that I took today.

Mama_mar_26_2015

Why HIPAA Won’t Save You: Protecting Data Privacy

This weekend, I had the fortune to speak (and attend) SXSW Interactive Festival for the first time. I wanted to take the opportunity to share here some of the perspectives I brought to the panel titled “Why HIPAA Won’t Save You: Protecting Data Privacy” with my colleagues Amanda Sheldon (Medtronic Diabetes), Jane Sarasohn-Kahn (THINK-Health and Health Populi blog) and Marc Monseau (Mint Collective LLC).

Recent data breaches have made the American public more aware about the issue of privacy, and potential for their health information to end up in unwanted hands.

Still most people do not bother to scroll through a lengthy Privacy Policy, Consent Form, or Terms of Use… though we probably should! On page 30 there may be a provision that could very well allow the company providing us with the tool or service to sell or share your data in ways that you may not be OK with.

What can be done to make this process easier on the patient?

  • People with visual disabilities may struggle reading below certain font sizes (I am one of them!!), and legal documents are also frequently referred to as “the fine print”. It would make sense to use a bigger font for the most sensitive parts of the document.
  • People learn from information differently: there are people who are visual learners, there are people who are auditory learners, etc. and even if all people could become informed by reading alone, lengthy documents make them ineffective. Having a 1-pages summary or an infographic with key elements from the policy would be a tremendous advance on this front.
  • People’s literacy level (health literacy, ability to understand legalese) can also get in the way. Even if the information is there and it’s accessible to the patient, they may not be able to understand what it means.
  • Last, even if you understand what the information means, you may not be able to understand the mid-to-long term implications. This is the hardest item to address, because it involves implications that may not be apparent today.

As my friend, Health Policy Attorney, and Patient Advocate, Erin Gilmer told me:

HIPAA is meant to give patient rights and ensure patients can trust that the system will keep their PHI safe – only used for treatment and payment purposes. [But] it has not yet evolved to tackle the sharing of data via social media or apps or websites or forums.

Makers of apps, devices, etc. where health data is being collected and/or shared need to do the right thing for the patient. That will go a long way towards protecting their privacy:

  • Almost every piece of data that is collected about someone using your product could have health implications: GPS data, mobile device usage, etc. so it needs to be treated with the same care as an A1c, weight, or cholesterol value.
  • Only data that is needed to do the job should be collecting. Just because you can ask for a piece of data doesn’t mean that you should, if you are not going to use it.
  • If you need to collect a piece of data, first default to do it in an anonymized or aggregated fashion, if it can give you the information you need.
  • If you are going to use the piece of data that is personally identifiable information, remember the Mom Test that Jane talks about: would you trust the system with your own mother’s data?
  • Don’t hide behind regulation or lack of guidance to justify the small print, the cryptic language, or the obscure links. KISS = Keep It Simple and Stupid!
  • People will not necessarily resent that their data is sold, as part of their usage of the product. But two things need to happen for this to work out: (1) they need to get a compelling benefit from the experience (and often it’s not a monetary incentive, but rather a sense of being part of something bigger, advancing science, etc.) ; (2) they need to CLEARLY understand that their data could be sold, and probably be told so again as it’s about to happen (always remember they are on the driver’s seat). A great example of how this has been done well is PatientsLikeMe.
  • Life happens and health changes with it, so products we interact with should allow us to update our privacy preferences easily at any point. Reminders about what is being done with your data, or what parts of your data are being used in ways that could affect your privacy build an environment of trust that is essential for a healthy ongoing relationship with your customers. “When data is your primary currency, trust is fundamental for your business.”
  • Every maker should provide users with a way to access their data easily in a truly portable format. A PDF is not a portable format (no matter what the acronym may stand for). Data siloed behind a company’s walls is not portable. Remember: the patient is in the driver’s seat and they OWN their data. Just because a company collects data doesn’t mean they own it. They are mere stewards of our data.

At the end of the day, it’s about placing the interests of the patient first and doing so with transparency and openness. While it is perfectly fine for companies to protect themselves, it cannot be done at the expense of the interests and the privacy of the consumer. This is something where everyone (patients, companies, and regulating entities) have a role to play.

Thank you to the following people whose incredible insights that helped make my participation (hopefully) more useful to those in attendance:

  • Erin Gilmer – Health Policy Attorney, and Patient Advocate (@GilmerHealthLaw)
  • Dana Lewis – Moderator for #hcsm, Patient Advocate (@danamlewis)
  • Melissa Lee – Exec. Director for Diabetes Hands Foundation, Patient Advocate (@sweetlyvoiced)
  • Brian Cohen- Lead Administrator for TuDiabetes.org, Patient Advocate
  • Other generous members of TuDiabetes.org

A letter to the TuDiabetes and EsTuDiabetes community

Earlier today, we shared this news on TuDiabetes and EsTuDiabetes…

linkedin

HOLA!

I hope you had a restful holiday in the company of your loved ones.

As 2015 kicks in, I have some important news to share about Diabetes Hands Foundation (DHF) and me.

Thursday, April 30 will be my last day as part of the staff at DHF, the nonprofit that since 2008 has been behind TuDiabetes, EsTuDiabetes, the Big Blue Test, and in recent years, the Diabetes Advocates program.

I am very excited to announce that Melissa Lee is coming on as Interim Executive Director effective today, January 15, 2015. As you may know, Melissa has deep history with DHF. She was one of the first administrators of TuDiabetes and became our first Lead Administrator, as well. She joined the Board of Directors in 2012 and has served as Secretary to the Board for the past two years. In addition, Melissa is on the steering committee of Diabetes Advocates. You may also know her from her contributions to A Sweet Life, where she is the Tech Editor, and her own blog, Sweetly Voiced.

As she takes on this role, I will continue at DHF, supporting her transition and having an active role in the project to migrate our online communities. As Melissa and I navigate this transition for the organization, the Board has started the search process for a permanent Executive Director.

As the co-founder of the organization, this was not an easy decision for me to make, but it is the right moment for it as I plan for my family’s future. I am confident that DHF has the leadership at the staff and board levels to manage these changes successfully. I want to thank them ALL for their unconditional and humbling support throughout this process!

After I step down, I won’t become a stranger to DHF or to diabetes. I anticipate that I will always have a relationship with DHF. In fact, I look forward to serving as an advisor to the organization, and in any other capacity that I can be of value to DHF. I am also truly excited about the prospect of getting involved in diabetes and pre-diabetes in additional ways. I will be posting about my next steps on social media soon.

This is a change for me, but DHF remains committed to continue to deliver on its mission. We all count on your support and partnership in 2015 and beyond to positively impact the lives of millions of people touched by diabetes.

Let me know if you have any questions. You can also read the announcement we published on the DHF web site.

Your friend in diabetes,